Latest Breaking News On - Office of the assistance - Page 1 : vimarsana.com
Nachrichtenquelle: globenewswire | 16.06.2021, 00:08 | 105 | 0 VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced preliminary, unaudited financial results for the fiscal fourth quarter 2021. For the fiscal quarter ending June 30, 2021, AVITA Medical has to date realized total revenue in excess of its fiscal fourth quarter guidance range of $8.2 million to $8.6 million. Based on the strength of both RECELL commercial revenue and BARDA related revenue, the Company is raising fiscal Q4 guidance to be in the range of $9.5 - $9.7 million, consisting of $6.0 - $6.2 million of
AustraliaMelbourneVictoriaValenciaCaraboboVenezuelaHuman-service-biomedical-advanced-researchUs-department-of-healthOffice-of-the-assistanceDevelopment-authorityNasdaq